NTT Poised to Start Dual-Currency Bond Sale to Refinance M&A
Subsidiary NTT Finance Corp. has hired banks to arrange calls from Monday for a potential multi-tranche debt offering in dollars and euros, according to a person with knowledge of the matter. NTT is set to tap investors at a time when credit spreads in global markets have tightened back to near their lowest since the global financial crisis, a Bloomberg index shows, as investor concerns about trade and the US economy have eased.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Apple is a star (again) as investors hope tariffs don't squeeze markets
Apple is a star (again) as investors hope tariffs don't squeeze markets originally appeared on TheStreet. Stocks had a nifty week last week, especially technology shares. All of the major averages had solid weeks. The Standard & Poor's 500 index rose 2.4%, its best week since June. The Nasdaq Composite Index jumped 3.87%. Its compadre, the Nasdaq-100 Index, added 3.73%. The small-cap Russell 2000 Index moved up 2.38%. And the venerable Dow Jones Industrial Average managed a 1.35% gain. The market's gains came as new tariff rates for goods exported to the United States seemed to settle in at around 15%, with a number of deals not yet finished with a number of countries, including Canada, China and Mexico. What's not clear is the effects tariffs might have on the domestic economy and has added volatility to financial markets. There is a lawsuit now before the U.S. Court of Appeals arguing that the president can not impose tariffs unilaterally. Some stocks had positively gaudy returns. Palantir Technologies () added 21.19% on the week after reporting its second-quarter revenue hit $1 billion, up 48% from a year earlier. It projected $4 billion-plus in revenue for the Networks () jumped 18.4%, and Axon Enterprise () , maker of the Taser and other equipment targeted at law enforcement, rose 13.5%. But there have to be losers, and there were: Eli Lilly () , off nearly 18% Thursday because orforglipron, its GLP-1 weight-loss that can be taken with a pill, didn't perform as well as Novo Nordisk's Wegovy in the latest trial. It was the biggest one-day loss for Lilly in 25 years. The Trade Desk () , an advertising platform that helps advertisers reach audiences across many channels, fell 37%.Apple reminds people they're still around Here we have to note Apple () , a stock many people currently loathe. The iPhone is wonderful, they'll say. So is the Macintosh computer. The graphics are great. But where's the artificial intelligence? Apple doesn't have an AI product to compete directly against Microsoft, Meta Platforms () and Google-parent Alphabet () At the end of July, Apple was down 17.1% for the year. This week, Apple shares were up 13.3%, sixth-best among S&P 500 stocks and the 2024 stock price decline has been cut to 8.4%. Reason: CEO Tim Cook said the company will invest an extra $100 billion on new plants in the United States. In exchange, the Trump Administration agreed to waive tariffs on Apple products made in China and India. Its market cap has risen to $3.4 trillion. Tech led the sectors Among the 11 S&P 500 sectors, technology had the best week, rising 4.27%, followed by Consumer Discretionary at 3.81% and Communications Services. Techs were led by Palantir, Arista Networks, Micron Technology () and Apple. Only three sectors were down on the week: Real Estate, down 0.14%. Health Care, down 0.8%. Energy, down 1%. Crude oil is down 11.7% on the year. The overall S&P 500 Index is up 8.63% and 32% from the bottom after President Trump introduced what's proven to be a first draft of a tariff plan. More Experts Stocks & Markets Podcast: Sectors to Avoid With Jay Woods Trader makes bold call with Boeing stock after defense workers strike Veteran fund manager sends urgent 9-word message on stocks But . . . There's always a catch After the market's decent-to-strong performance this past week, maybe in the back of your mind, you're thinking: Relatively speaking, how does it compare. Nicely, as noted. But the S&P 500 Index, used often as a short hand for the market, hasn't had a record close in (gasp!) nine whole days. Is this the end of the world? Probably not. The index has already seen 15 record closes in 2025, and autumn has not yet arrived. In 2024, in part because of the presidential election, there were 29 new record closes between July 26 and the end of the all, the index generated 57 new closing highs in 2024, according to Howard Silverblatt, Standard & Poor's senior index analyst. The record is still 77 closing highs in 1995. And that was as the Internet Bubble of the late 1990s was just getting started. The timing of new highs quite variable. The S&P 500 hit a closing high of 6,144.15 on Feb. 15. It took 128 days — and the tariff-induced minicrash in April — before the index hit a new record close: 6,173 on June 27. What's ahead for the market? The week ahead includes 621 earnings reports, a goodly number until you remember that last week 1,552 companies reported quarterly results. All will mention tariffs somehow. The reports expected to grab the most attention will be: Dow component Cisco Systems () , due after Wednesday's close. Cisco makes routers and networking equipment. Revenue estimate: $14.5 billion, up 7% from a year ago. Earnings estimate is 91 cents a share, up 4.6%. Chip-equipment maker Applied Materials () , after Thursday's close. The revenue estimate: $7.2 billion, up 5.4% from a year ago. Earnings estimate: $2.35 a share, up 10.9%. Farm-equipment maker Deere & Co. () , before Thursday's open. Revenue estimate: $10.3 billion, down 21.7%. Earnings estimate: $4.60, down 27%. Tapestry () , the owner of Coach leather goods and Kate Spade New York. Revenue estimate: $1.7 billion, up 5.4% from a year ago. Earnings estimate: $1, up 8.7%. Apple is a star (again) as investors hope tariffs don't squeeze markets first appeared on TheStreet on Aug 10, 2025 This story was originally reported by TheStreet on Aug 10, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
Results: NCR Atleos Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
Explore NCR Atleos's Fair Values from the Community and select yours NCR Atleos Corporation (NYSE:NATL) investors will be delighted, with the company turning in some strong numbers with its latest results. It was overall a positive result, with revenues beating expectations by 2.0% to hit US$1.1b. NCR Atleos also reported a statutory profit of US$0.60, which was an impressive 22% above what the analysts had forecast. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Taking into account the latest results, NCR Atleos' six analysts currently expect revenues in 2025 to be US$4.35b, approximately in line with the last 12 months. Per-share earnings are expected to leap 47% to US$2.56. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$4.31b and earnings per share (EPS) of US$2.55 in 2025. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates. Check out our latest analysis for NCR Atleos With the analysts reconfirming their revenue and earnings forecasts, it's surprising to see that the price target rose 12% to US$44.67. It looks as though they previously had some doubts over whether the business would live up to their expectations. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on NCR Atleos, with the most bullish analyst valuing it at US$60.00 and the most bearish at US$34.00 per share. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation. Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. One thing stands out from these estimates, which is that NCR Atleos is forecast to grow faster in the future than it has in the past, with revenues expected to display 3.7% annualised growth until the end of 2025. If achieved, this would be a much better result than the 0.5% annual decline over the past year. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 8.0% annually for the foreseeable future. Although NCR Atleos' revenues are expected to improve, it seems that the analysts are still bearish on the business, forecasting it to grow slower than the broader industry. The Bottom Line The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving. With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for NCR Atleos going out to 2027, and you can see them free on our platform here. Plus, you should also learn about the 2 warning signs we've spotted with NCR Atleos (including 1 which is concerning) . Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
Axogen Second Quarter 2025 Earnings: Beats Expectations
Explore Axogen's Fair Values from the Community and select yours Axogen (NASDAQ:AXGN) Second Quarter 2025 Results Key Financial Results Revenue: US$56.7m (up 18% from 2Q 2024). Net income: US$579.0k (up from US$1.92m loss in 2Q 2024). Profit margin: 1.0% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. EPS: US$0.013 (up from US$0.044 loss in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Axogen Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 7.7%. Earnings per share (EPS) also surpassed analyst estimates. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are up 9.7% from a week ago. Risk Analysis You should learn about the 1 warning sign we've spotted with Axogen. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
